Title
Treatment of Immune Thrombocytopenia
Authoring Organization
Publication Month/Year
December 3, 2019
Last Updated Month/Year
April 2, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the management of ITP.
Target Patient Population
ITP in adults and children with newly diagnosed, persistent, and chronic disease refractory to first-line therapy who have non–life-threatening bleeding
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Prevention, Management, Treatment
Diseases/Conditions (MeSH)
D013921 - Thrombocytopenia, D007107 - Immune System, D013920 - Thrombocythemia, Essential
Keywords
corticosteroids, thrombocytopenia, Immune-Related Adverse Events
Source Citation
Blood Adv (2019) 3 (23): 3829–3866.
https://doi.org/10.1182/bloodadvances.2019000966